Patient-derived xenograft (PDX) models of BRCA-deficient and BRCA-like ovarian tumors reflect clinical responses to PARP inhibitionA. Davies,J. Hou, L.M. Shih,J.D. Wright,Daniel Ciznadija,A. Katz,David SidranskyEUROPEAN JOURNAL OF CANCER(2016)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要